1. Germany Diabetes Care Devices Market Outlook to 2018-
Glucose Monitoring and Insulin Delivery
Report Details:
Published:September 2012
No. of Pages: 99
Price: Single User License – US$2500
Germany Diabetes Care Devices Market Outlook to 2018- Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “Germany Diabetes Care Devices Market Outlook to 2018- Glucose
Monitoring and Insulin Delivery” provides key market data on the Germany Diabetes Care Devices
market. The report provides value (USD million), volume (units) and average price (USD) data for
each segment and sub-segment within two market categories – Glucose Monitoring and Insulin
Delivery. The report also provides company shares and distribution shares data for each of the
aforementioned market categories. The report is supplemented with global corporate-level profiles
of the key market participants with information on company financials and pipeline products,
wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for Diabetes Care Devices market categories – Glucose
Monitoring and Insulin Delivery.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for
each of the segments and sub-segments within two market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the two market categories.
- Global corporate-level profiles of key companies operating within the Germany Diabetes Care
Devicesmarket.
- Key players covered include F. Hoffmann-La Roche Ltd., Sanofi, Medtronic, Inc., Eli Lilly and
Company, LifeScan, Inc., Novo Nordisk A/S and others.

2. Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Germany Diabetes Care
Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/197487-germany-diabetes-care-devices-market-outlook-to-2018-glucose-
monitoring-and-insulin-delivery.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 9
2.1 What is This Report About? 9
3 Diabetes Care Devices In Germany 10
3.1 Diabetes Care Devices, Market Segmentation 10
3.2 Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 11
3.3 Diabetes Care Devices Market, Germany, Revenue Mix ($m), 2011 12
3.4 Diabetes Care Devices Market, Germany, Category Contribution (%), 2011 13
3.5 Diabetes Care Devices, Germany, Company Share (2010-2011) 20
4 Glucose Monitoring In Germany 22
4.1 Glucose Monitoring, Market Segmentation 22
4.2 Glucose Monitoring Market, Germany, Revenue Mix ($m), 2011 23
4.3 Glucose Monitoring Market, Germany, Segment Contribution (%), 2011 24
4.4 Glucose Monitoring Overall Revenue, (2004-2018). 25
4.4.1 Blood Glucose Meters, Revenue (2004-2018) 29
4.5 Glucose Monitoring Overall Volume (2004-2018) 33
4.5.1 Blood Glucose Meters, Volume (2004-2018) 37
4.6 Glucose Monitoring Average Price (2004-2018) 41
4.7 Glucose Monitoring Distribution Share (2010-2011) 42
4.8 Glucose Monitoring, Germany, Company Share (2010-2011) 43
5 Insulin Delivery In Germany 45
5.1 Insulin Delivery Market, Germany, Revenue Mix ($m), 2011 46
5.2 Insulin Delivery Market, Germany, Segment Contribution (%), 2011 47

3. 5.3 Insulin Delivery Overall Revenue, (2004-2018) 48
5.3.1 Insulin Pens, Revenue (2004-2018) 52
5.3.2 Insulin Pumps, Revenue (2004-2018) 56
5.4 Insulin Delivery Overall Volume (2004-2018) 60
5.4.1 Insulin Pens, Volume (2004-2018) 64
5.4.2 Insulin Pumps, Volume (2004-2018) 68
5.5 Insulin Delivery Average Price (2004-2018) 71
5.6 Insulin Delivery Distribution Share (2010-2011) 72
5.7 Insulin Delivery, Germany, Company Share (2010-2011) 73
6 Overview of Key Companies in Germany Diabetes Care Devices Market 75
6.1 F. Hoffmann-La Roche Ltd. 75
6.1.1 Company Overview 75
6.1.2 Share in the Germany Diabetes Care Devices Market 75
6.2 Sanofi 76
6.2.1 Company Overview 76
6.2.2 Share in the Germany Diabetes Care Devices Market 76
6.3 Medtronic, Inc. 77
6.3.1 Company Overview 77
6.3.2 Share in the Germany Diabetes Care Devices Market 77
6.4 Eli Lilly and Company 78
6.4.1 Company Overview 78
6.4.2 Share in the Germany Diabetes Care Devices Market 78
6.5 LifeScan, Inc. 79
6.5.1 Company Overview 79
6.5.2 Share in the Germany Diabetes Care Devices Market 79
6.6 Novo Nordisk A/S 80
6.6.1 Company Overview 80
6.6.2 Share in the Germany Diabetes Care Devices Market 80
6.7 Bayer HealthCare AG 81
6.7.1 Company Overview 81
6.8 Abbott Laboratories 81
6.8.1 Company Overview 81
6.9 Becton, Dickinson and Company 82
6.9.1 Company Overview 82
6.10 Animas Corporation 82
6.10.1 Company Overview 82
6.11 Ypsomed Holding AG 83
6.11.1 Company Overview 83
6.12 ARKRAY, Inc. 83
6.12.1 Company Overview 83
6.13 B. Braun Melsungen AG 84
6.13.1 Company Overview 84

4. 6.14 Terumo Corporation 84
6.14.1 Company Overview 84
7 Diabetes Care Devices Market Pipeline Products 85
8 Financial Deals Landscape 89
8.1 Partnerships 89
8.1.1 Insulet Expands Distribution Agreement With Ypsomed Holding 89
9 Recent Developments 90
9.1 Strategy And Business Planning 90
9.1.1 Jun 26, 2012: Roche To Shut New Jersey Site, Eliminate 1,000 Jobs 90
9.2 Research And Development 91
9.2.1 Mar 27, 2012: Bayer HealthCare And Tsinghua University Extend Innovative Drug Discovery
Partnership 91
9.2.2 Jan 09, 2012: Bayer HealthCare To Share Lab Space With Start-Up Companies 91
9.3 Product News 92
9.3.1 Sep 08, 2008: Novo Nordisk Launches A Next Generation Of FlexPen 92
10 Appendix 93
10.1 Definitions of Markets Covered in the Report 94
10.1.1 Diabetes Care Devices 94
10.2 Research Methodology 96
10.3 Secondary Research 96
10.4 Primary Research 97
10.5 Models 97
10.6 Forecasts 98
10.7 Expert Panels 98
10.8 GlobalData Consulting 98
10.9 Currency Conversion 98
10.10 Contact Us 98
10.11 Disclaimer 99
1.1 List of Tables
Table 1: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 11
Table 2: Diabetes Care Devices Market, Germany, Category Contribution (%), 2011 13
Table 3: Diabetes Care Devices, Germany, Cross-Segment Analysis, 2004-2018 15
Table 4: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 17
Table 5: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Forecast,
2011-2018 19
Table 6: Diabetes Care Devices, Germany, Company Share by Revenue ($m), USD Constant,
2010-2011 21
Table 7: Glucose Monitoring Market, Germany, Segment Contribution (%), 2011 24
Table 8: Glucose Monitoring, Germany, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 26

5. Table 9: Glucose Monitoring, Germany, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 28
Table 10: Blood Glucose Meters, Germany, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 30
Table 11: Blood Glucose Meters, Germany, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 32
Table 12: Glucose Monitoring, Germany, Volume (Units) by Segment, Historic, 2004-2011 34
Table 13: Glucose Monitoring, Germany, Volume (Units) by Segment, Forecast, 2011-2018 36
Table 14: Blood Glucose Meters, Germany, Volume (Units) by Sub-Segment, Historic, 2004-2011
38
Table 15: Blood Glucose Meters, Germany, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 40
Table 16: Glucose Monitoring, Germany, Average Price ($), Historic, 2004-2011 41
Table 17: Glucose Monitoring, Germany, Average Price ($), Forecast, 2011-2018 41
Table 18: Glucose Monitoring, Germany, Distribution Share by Revenue ($m), USD Constant,
2010-2011 42
Table 19: Glucose Monitoring, Germany, Company Share by Revenue ($m), USD Constant, 2010-
2011 44
Table 20: Insulin Delivery Market, Germany, Segment Contribution (%), 2011 47
Table 21: Insulin Delivery, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 49
Table 22: Insulin Delivery, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 51
Table 23: Insulin Pens, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 53
Table 24: Insulin Pens, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 55
Table 25: Insulin Pumps, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 57
Table 26: Insulin Pumps, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 59
Table 27: Insulin Delivery, Germany, Volume (Units) by Segment, Historic, 2004-2011 61
Table 28: Insulin Delivery, Germany, Volume (Units) by Segment, Forecast, 2011-2018 63
Table 29: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Historic, 2004-2011 65
Table 30: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Forecast, 2011-2018 67
Table 31: Insulin Pumps, Germany, Volume (Units) by Sub-Segment, Historic, 2004-2011 68
Table 32: Insulin Pumps, Germany, Volume (Units) by Sub-Segment, Forecast, 2011-2018 70
Table 33: Insulin Delivery, Germany, Average Price ($), Historic, 2004-2011 71
Table 34: Insulin Delivery, Germany, Average Price ($), Forecast, 2011-2018 71
Table 35: Insulin Delivery, Germany, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 72
Table 36: Insulin Delivery, Germany, Company Share by Revenue ($m), USD Constant, 2010-

6. 2011 74
Table 37: Diabetes Care Devices Market Pipeline Products 85
Table 38: Insulet Expands Distribution Agreement With Ypsomed Holding 89
1.2 List of Figures
Figure 1: Diabetes Care Devices, Market Segmentation 10
Figure 2: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, 2004-2018 11
Figure 3: Diabetes Care Devices Market, Germany, Revenue Mix ($m), 2011 12
Figure 4: Diabetes Care Devices Market, Germany, Category Contribution (%), 2011 13
Figure 5: Diabetes Care Devices, Germany, Cross-Segment Analysis, 2004-2018 14
Figure 6: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 16
Figure 7: Diabetes Care Devices, Germany, Overall Revenue ($m), USD Constant, Forecast,
2011-2018 18
Figure 8: Diabetes Care Devices, Germany, Company Share (%)-2011 20
Figure 9: Glucose Monitoring, Market Segmentation 22
Figure 10: Glucose Monitoring Market, Germany, Revenue Mix ($m), 2011 23
Figure 11: Glucose Monitoring Market, Germany, Segment Contribution (%), 2011 24
Figure 12: Glucose Monitoring, Germany, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 25
Figure 13: Glucose Monitoring, Germany, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 27
Figure 14: Blood Glucose Meters, Germany, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 29
Figure 15: Blood Glucose Meters, Germany, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 31
Figure 16: Glucose Monitoring, Germany, Volume (Units) by Segment, Historic, 2004-2011 33
Figure 17: Glucose Monitoring, Germany, Volume (Units) by Segment, Forecast, 2011-2018 35
Figure 18: Blood Glucose Meters, Germany, Volume (Units) by Sub-Segment, Historic, 2004-2011
37
Figure 19: Blood Glucose Meters, Germany, Volume (Units) by Sub-Segment, Forecast, 2011-
2018 39
Figure 20: Glucose Monitoring, Germany, Company Share (%), 2011 43
Figure 21: Insulin Delivery, Market Segmentation 45
Figure 22: Insulin Delivery Market, Germany, Revenue Mix ($m), 2011 46
Figure 23: Insulin Delivery Market, Germany, Segment Contribution (%), 2011 47
Figure 24: Insulin Delivery, Germany, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 48
Figure 25: Insulin Delivery, Germany, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 50
Figure 26: Insulin Pens, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-
2011 52

7. Figure 27: Insulin Pens, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 54
Figure 28: Insulin Pumps, Germany, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 56
Figure 29: Insulin Pumps, Germany, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 58
Figure 30: Insulin Delivery, Germany, Volume (Units) by Segment, Historic, 2004-2011 60
Figure 31: Insulin Delivery, Germany, Volume (Units) by Segment, Forecast, 2011-2018 62
Figure 32: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Historic, 2004-2011 64
Figure 33: Insulin Pens, Germany, Volume (Units) by Sub-Segment, Forecast, 2011-2018 66
Figure 34: Insulin Pumps, Germany, Volume (Units) by Sub-Segment, Historic, 2004-2011 68
Figure 35: Insulin Pumps, Germany, Volume (Units) by Sub-Segment, Forecast, 2011-2018 69
Figure 36: Insulin Delivery, Germany, Company Share (%), 2011 73
Figure 37: F. Hoffmann-La Roche Ltd., Company Share (%),Germany Diabetes Care Devices
Market, 2011 75
Figure 38: Sanofi, Company Share (%),Germany Diabetes Care Devices Market, 2011 76
Figure 39: Medtronic, Inc., Company Share (%),Germany Diabetes Care Devices Market, 2011 77
Figure 40: Eli Lilly and Company, Company Share (%),Germany Diabetes Care Devices Market,
2011 78
Figure 41: LifeScan, Inc., Company Share (%),Germany Diabetes Care Devices Market, 2011 79
Figure 42: Novo Nordisk A/S, Company Share (%),Germany Diabetes Care Devices Market, 2011
80
Contact: sales@reportsandreports.com for more information.